EphA1 Antibodies

Santa Cruz Biotechnology provides a broad selection of EphA1 monoclonal antibodies for research in understanding EphA1's role in various biological processes. EphA1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). EphA1, a member of the Eph receptor family, plays a crucial role in cell signaling, particularly in processes such as cell adhesion, migration, and differentiation. EphA1 is involved in the development of the nervous system and has been implicated in various diseases, including cancer and neurological disorders. Understanding EphA1 function is essential for elucidating its potential as a therapeutic target. EphA1 monoclonal antibodies enable researchers to investigate specific protein interactions and signaling pathways. Studying EphA1 expression patterns helps reveal its role in tissue development and disease progression. Advanced visualization techniques using EphA1 monoclonal antibodies allow for detailed analysis of cellular localization and protein dynamics. Santa Cruz Biotechnology monoclonal antibodies for EphA1 research support scientists worldwide in advancing our understanding of cellular processes and disease mechanisms.